Generate a tailored SOP for Dr. Charlie Birts. Improve your application with a focused, well-structured draft.
Dr. Charlie Birts is a Lecturer in Antibody Therapeutics at the University of Southampton, focusing on breast cancer research. He holds a First-Class Honours degree in Biochemistry and Pharmacology from the University of Southampton (2003) and completed his PhD under David Wilton, studying phospholipases in inflammation. He joined Dr. Jeremy Blaydes’ lab at Southampton General Hospital Faculty of Medicine as a postdoctoral researcher in 2007, examining the molecular mechanisms that control metabolic changes in breast cancer cells, particularly interacting with the CtBP protein family. Awarded the Faculty of Medicine Postdoctoral Career Track Award in 2014, he initiated independent research into metabolic interactions in the tumor microenvironment. Dr. Birts was granted the ESPEN Research Fellowship in 2016 to explore the relationship between cancer metabolism and the immune system. In 2018, he became a lecturer at the School of Biological Sciences, funded by Against Breast Cancer, where he develops novel antibody-based therapies aimed at treating secondary breast cancers and investigates immune responses in oncologic contexts. His current work also involves identifying glycan biomarkers for novel therapeutic targets and improving antibody efficacy in treating breast cancer metastasis.
University of Southampton • Southampton
Teaching and researching in the field of Antibody Therapeutics, with a focus on breast cancer.
Southampton General Hospital Faculty of Medicine • Southampton
Investigated molecular mechanisms of cellular metabolism in breast cancer.